Genetic Clue Found To The Leading Cause Of Blindness In The United States

August 13, 1998

OHSU Researchers Find The Location Of A Gene Linked To Age-Related Macular Degeneration

(Portland, OR) -- Retired schoolteacher Ruth Oster lives with a small spot that blocks off part of the central vision in her left eye.

"I first noticed it about 15 years ago," said Oster, who lives in a rural area northwest of Portland. "I was trying to type a paper, and it just took tremendous effort to see the letters. The spot would move wherever I was trying to read." Now, Oster is unable to drive at night and she struggles to read music when playing the violin, one of her favorite activities. New research by a team at the Macular Degeneration Center at Oregon Health Sciences University's Casey Eye Institute shows the disease that's blurring Oster's vision has a genetic cause. The research was done in collaboration with scientists at the Laboratory of Statistical Genetics at Rockefeller University in New York.

Like Oster, millions of Americans suffer from a gradual fading-out of central vision known as age-related macular degeneration. Roughly 7 percent of Americans older than 75 have progressed to the late stage of the disease. The loss of vision comes from deterioration of a particularly sensitive area of the retina called the macula. The team of scientists has zeroed in on the location of a gene that causes an inherited form of the disease. Details of this research appear in the August edition of the Archives of Ophthalmology.

The team of researchers, led by Michael Klein, M.D., professor of ophthalmology at OHSU, studied 21 individuals from Oster's family; 10 of them with age-related macular degeneration.

"It has been difficult to find a genetic cause for this disease," said Klein. "It has a late age of onset, can take one of several forms and is difficult to diagnose early. By studying a large family affected by the disease, we could compare genetic information from family members and determine differences between affected and unaffected individuals."

The researchers employed a technique called "linkage analysis" to zero in on the location of the macular degeneration gene. The technique involves comparing short segments of DNA from affected and unaffected individuals. The affected individuals share variations in their genetic material that are not found in the general population.

"Starting with a genome-wide search, we narrowed down the location of the gene in this family to an area of chromosome 1," said Dennis Schultz, Ph.D., a research assistant professor of ophthalmology at OHSU. Specifically, the gene is located in an area referred to as chromosome 1q25-q31.

"It's a little like finding out the gene is living along a certain street, but not knowing which house it's in," said Schultz. "Further research will focus on uncovering the exact street address of the gene." Previous research has focused on a gene in a different area of chromosome 1 that causes a juvenile form of macular degeneration and also may be associated with age-related macular degeneration. But this is the first published research to identify the location of a genetic defect in a large family with age-related macular degeneration.

Age-related macular degeneration has been a major focus of genetic research both because it is so common and because it is so difficult to treat. The most effective current treatment is a technique called laser photocoagulation, in which a laser beam is used to slow down the so-called "wet" form of the disease. In this form, new blood vessels grow underneath the retina, than leak, bleed and form scar tissue. The degeneration process usually occurs rapidly, over weeks or months, and often profoundly affects central vision. But the wet form accounts for less than 20 percent of cases, and there is no treatment for "dry" age-related macular degeneration. The dry form of the disease results from progressive damage to the pigment cell layer of the retina. Vision loss occurs slowly, usually over years, and is less severe than that caused by the wet form of the disease. The ability to do genetic screening for the disease could help physicians anticipate which patients are at risk and take early preventative measures to head off a significant loss of vision. An ultimate goal of the research is to develop measures and therapies that can eliminate age-related macular degeneration.

"We believe this genetic research will help us accomplish this goal by leading us to a better understanding of the basic cause of the disease," said Klein.

Ruth Oster said she's glad her family was able to be part of this discovery, even though a cure for the disease may still be far off. "The whole family has sort of accepted it," she said. "It would be great if I can continue to play music and keep passing the driver's exam. And it's good to know that eventually they'll find a way to slow down or stop this disease."

The Macular Degeneration Center is interested in studying other families with a high incidence of age-related macular degeneration. Those who are members of a family in which at least three living relatives have the disease are encouraged to contact the center at (503) 494-3064.

Dr. Klein and Ruth Oster are both available for interviews. Please contact Henry Sessions at (503) 494-8231 to arrange a time. A copy of the full Archives journal article is also available on request.

This study was supported by the George and Carolyn Goodall Foundation, the Joseph E. Paquet Fund, the Frances and Monroe Jubitz Fund, the Macular Degeneration Center Fund, the Collins Medical Trust, an unrestricted grant from Research to Prevent Blindness, the Foundation Fighting Blindness, the Heed Foundation and the Medical Research Foundation of Oregon.

In addition to Klein and Schultz, investigators on this project were Ted Acott, Ph.D.; Blair Berselli; Albert Edwards, M.D., Ph.D.; Richard Weleber, M.D.; and Mary Wirtz, Ph.D.; all of Oregon Health Sciences University. Also included are Tara Matise, Ph.D., and Jurg Ott, Ph.D., of the Laboratory of Statistical Genetics at Rockefeller University.

Oregon Health & Science University

Related Macular Degeneration Articles from Brightsurf:

Levodopa may improve vision in patients with macular degeneration
Investigators have determined that treating patients with an advanced form of age-related macular degeneration (AMD) with levodopa, a safe and readily available drug commonly used to treat Parkinson's disease, stabilized and improved their vision.

Combating drug resistance in age-related macular degeneration
An international team of researchers led by Baylor College of Medicine and Houston Methodist has discovered a strategy that can potentially address a major challenge to the current treatment for age-related macular degeneration,

Study finds unexpected suspect in age-related macular degeneration
Scientists have identified an unexpected player in the immune reaction gone awry that causes vision loss in patients with age-related macular degeneration (AMD), according to a new study published today in eLife.

Potential way to halt blinding macular degeneration identified
It would be the first treatment for dry age-related macular degeneration and could significantly improve treatment for wet AMD.

Heating techniques could improve treatment of macular degeneration
Age-related macular degeneration is the primary cause of central vision loss and results in the center of the visual field being blurred or fully blacked out.

Eye's vulnerability to macular degeneration revealed
Scientists have found significant differences in the shape and biology of the same type of cell taken from different parts of the retina, according to a study in eLife.

Hallucinations associated with brain hyperactivity in people with macular degeneration
New research from The University of Queensland has shown for the first time that visual hallucinations in people with macular degeneration are associated with abnormally heightened activity in the visual cortex of the brain.

Eating leafy greens could help prevent macular degeneration
A new study has shown that eating vegetable nitrates, found mainly in green leafy vegetables and beetroot, could help reduce your risk of developing early-stage age-related macular degeneration (AMD).

An orange a day keeps macular degeneration away: 15-year study
A new study has shown that people who regularly eat oranges are less likely to develop macular degeneration than people who do not eat oranges.

Macular degeneration linked to aging immune cells
Studying mice and cells from patients, vision researchers at Washington University School of Medicine in St.

Read More: Macular Degeneration News and Macular Degeneration Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to